Medical Health & Life Science Research News

Detailed examination of the oligonucleotide synthesis market worth 1,918.6 million USD by 2020

Detailed examination of the oligonucleotide synthesis market worth 1,918.6 million USD by 2020

[248 Pages Report] Oligonucleotide Synthesis Market report categories the Global market by Application (Research, PCR, Gene, DNA, NGS, Diagnostic, RNAI), Product & Services (Primer, Probe, Custom Oligos, Reagent, Equipment), End user (Biotechnology, Academic, Pharmaceutical) & Geography

- Advertising -

Browse 183 market data Tables and 53 Figures spread through 229 Pages and in-depth TOC on "Oligonucleotide Synthesis Market"

www.marketsandmarkets.com/Market-R…m_campaign=PaidPR

Oligonucleotide Synthesis Market by Product & Services (Primer, Probe, Custom Oligos, Reagent, Equipment), Application (PCR, Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical & Biotech, Diagnostic Labs) - Global Forecast to 2020 analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

Download Sample Report @www.marketsandmarkets.com/requests….asp?id=200829350

In this report, the Oligonucleotide Synthesis Market is segmented based on products and services, applications, end users, and regions. On the basis of products and services, the Oligonucleotide Synthesis Market is segmented into synthesized oligonucleotides, reagents, and equipment.

- Advertising -

Synthesized oligonucleotides are expected to account for the largest share of the Oligonucleotide Synthesis Market in 2015. Growth in this segment is attributed to the increasing number of applications of synthesized oligonucleotides in research, diagnostics, and therapeutics.

The rising demand for custom oligos also contributes to the growth of the synthesized oligonucleotides market.

Among applications, the research applications segment dominates the market, whereas the diagnostic applications segment is expected to grow at the highest CAGR during the forecast period. Among end users, the diagnostic laboratories segment is expected to grow at the highest CAGR during the forecast period.

On the basis of regions, the Oligonucleotide Synthesis Market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America is expected to account for the largest share of this market in 2015.

However, APAC is expected to grow at the highest CAGR during the forecast period, owing to the growing availability of synthesized oligos, increase in R&D funding and activities, and increasing focus of prominent players in in the APAC region.

Get The PDF Brochure: www.marketsandmarkets.com/pdfdownl…m_campaign=PaidPR

The Oligonucleotide Synthesis Market is highly competitive, with the presence of several big as well as emerging market players. In addition, each product segment has a different set of vendors.

Key market players include Agilent Technologies (U.S.), BioAutomation Corporation (U.S.), Biosearch Technologies, Inc. (U.S.), Eurofins Genomics (Germany), Eurogentec (Belgium), GeneDesign, Inc. (Japan), GE Healthcare (U.K.), Integrated DNA Technologies (IDT) (U.S.), Sigma-Aldrich Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), TriLink BioTechnologies, Inc. (U.S.), Gen9, Inc. (U.S.), GenScript (U.S.), and Nitto Denko Avecia Inc. (Japan).

News From

MarketsandMarkets™ - Business ResearchMarketsandMarkets™
Category: Market Research Publishers and RetailersCompany profile: MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth ...